Close

BMO Capital Starts 4D Molecular Therapeutics (FDMT) at Outperform

January 30, 2023 2:16 AM EST Send to a Friend
BMO Capital analyst Kostas Biliouris initiates coverage on 4D Molecular Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login